Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter
News
Articles
Podcasts
Infographics
Spotlight: April 2024
Catch up on the top stories to come from the pharma industry over April, including new collaborations set to improve treatments for patients, the latest approvals and more.
Read more
BioMarin supports haemophilia documentary initiative
A new filmmaking project is sponsored by BioMarin Pharmaceutical to support people with haemophilia, exploring the healing and therapeutic power of arts and self expression.
FDA approves first-in-class cancer checkpoint inhibitor
A new type of checkpoint inhibitor to treat unresectable or metastatic melanoma has been approved by the FDA.
Industry welcomes UK-wide commitment to genomic research
Better genomic testing and access to clinical trials have been prioritised and agreed by the UK government and devolved administrations. Read for more details.
Treatment milestone for diabetes in pregnancy
After positive study results, metformin-based anti-diabetic medication from Merck has received a label extension for use throughout pregnancy. Find out more.
Rare disease action plan published
A new action plan for rare diseases has been published by the Department of Health and Social Care to mark Rare Diseases Day.
Spoonful of apps
GOLD showcases some standout apps created, or harnessed by, the pharma industry.
Sanofi and GSK seek COVID-19 vaccine approval
Sanofi and GSK are seeking regulatory approval for their adjuvanted protein-based COVID-19 vaccine, as a primary two-dose series and booster dose.
Spoonful of technology: February 2023
GOLD reviews the top stories in health technology from the past few months, highlighting how tech is changing treatment landscapes and patient experiences.
Loading posts...
« Previous
1
…
5
6
7
8
Next »